Skip to main content

Month: April 2020

Ipsos – L’impact de l’épidémie de Coronavirus (Covid-19) sur l’activité

Paris, 8 avril 2020 – Pendant les 10 premières semaines de 2020, Ipsos a réalisé son meilleur départ d’année depuis 2011. Le carnet de commandes était supérieur de plus de 5% et les perspectives de gains de nouveaux contrats se situaient à un niveau particulièrement élevé. Seuls la Chine et quelques autres marchés asiatiques étaient à l’arrêt.La situation s’est brutalement retournée à la mi-mars, dans beaucoup de régions du monde. Evidemment, le facteur déclenchant a été le confinement qui s’est mis en place dans les principaux pays d’Europe, aux Etats-Unis et dans d’autres pays, alors même qu’il n’était au mieux qu’assoupli dans quelques pays d’Asie.Pour l’ensemble du mois de mars, y compris les deux premières semaines, les commandes ont fléchi de 40%. Si on exclut les deux premières semaines du mois, la baisse est légèrement supérieure...

Continue reading

Indkaldelse til ordinær generalforsamling i Danske Invest Select

Indkaldelse til ordinær generalforsamlingDet skal hermed meddeles, at Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select afholder fælles ordinær generalforsamling torsdag den 23. april 2020, kl. 16.00 på foreningernes kontor, Parallelvej 17, 2800 Kgs. Lyngby.Grundet den helt særlige situation omkring COVID-19 henstiller vi til, at ingen investorer møder fysisk op til generalforsamlingen og gør opmærksom på, at der ikke vil være drikkevarer eller andet traktement i forbindelse med generalforsamlingen.Dagsorden er vedhæftet.Med venlig hilsen Robert Bruun MikkelstrupAdm. direktørVedhæftet filDI og DIS dagsorden 23.04.2020 + Bilag

Continue reading

Indkaldelse til ordinær generalforsamling i Danske Invest

Indkaldelse til ordinær generalforsamlingDet skal hermed meddeles, at Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select afholder fælles ordinær generalforsamling torsdag den 23. april 2020, kl. 16.00 på foreningernes kontor, Parallelvej 17, 2800 Kgs. Lyngby.Grundet den helt særlige situation omkring COVID-19 henstiller vi til, at ingen investorer møder fysisk op til generalforsamlingen og gør opmærksom på, at der ikke vil være drikkevarer eller andet traktement i forbindelse med generalforsamlingen.Dagsorden er vedhæftet.Med venlig hilsen Robert Bruun MikkelstrupAdm. direktørVedhæftet filDI og DIS dagsorden 23.04.2020 + Bilag

Continue reading

Heineken Holding N.V. withdraws all guidance for 2020 due to Covid-19

Amsterdam, 8 April 2020 – Heineken Holding N.V. (EURONEXT: HEIO; OTCQX: HKHHY) today issued the following statement.  With the spread of the Covid-19 crisis to all geographies, multiple countries have taken far-reaching containment measures such as restrictions of movement for populations and outlet closures, sometimes combined with the mandatory lockdown of production facilities. This constitutes a major negative macro-economic development and as such it is having a significant impact on HEINEKEN’s markets and on its business in 2020.In these very trying times, HEINEKEN’s priority is to ensure the health and welfare of its employees, customers, and business partners. All teams are mobilised to enable HEINEKEN to face this unprecedented crisis in the best possible way, and to protect the long-term potential of its brands and businesses.For...

Continue reading

QuestCap Appoints Richard Dolan and Jim Rogers to Advisory Board

TORONTO, April 08, 2020 (GLOBE NEWSWIRE) — QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the appointment of Richard Dolan and Jim Rogers to the Company’s strategic advisory board. Mr. Dolan’s extensive experience in wealth management and brand development will be indispensable to the QuestCap management team. Mr. Rogers, the acclaimed author, financial commentator, and international investor, brings a record of successful contrarian bets. Both will be valuable additions to the advisory board and will greatly assist QuestCap realize its vision of a sustainable, healthier future.“The time is now for private enterprise to rise up and mobilize the necessary financial bandwidth, focus and resources to bring this pandemic under control; and restore mankind’s relationship to community and commerce”,...

Continue reading

Update on AGM Procedure

LONDON, April 08, 2020 (GLOBE NEWSWIRE) — Verona Pharma plc (AIM: VRP) (Nasdaq: VRNA) (“Verona Pharma” or the “Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, provides an update on its upcoming Annual General Meeting (“AGM”), scheduled to be held at the offices of Shakespeare Martineau at 60 Gracechurch Street, London EC3V 0HR, United Kingdom at 10.30 a.m. on April 16, 2020.The Company currently plans to hold its AGM as scheduled, however given the UK Government’s present restrictions on public gatherings of more than two people, the Board requests shareholders to vote by proxy rather than attend the AGM in person. Any shareholders seeking to attend the AGM in person will be refused entry.By way of reminder, the deadline for delivery of...

Continue reading

NORBIT ASA – Notice of annual general meeting on 4 May 2020

Trondheim, 8 April 2020: The annual general meeting of NORBIT ASA will be held on Monday 4 May 2020 at 4:00 pm at the company’s head office in Stiklestadveien 1, 7041 Trondheim, Norway.Due to the COVID-19 situation and in order to comply with the advice of the authorities, NORBIT’s shareholders and other stakeholders are urged not to physically attend the meeting, but rather to use the available means to vote electronically or submit a proxy form prior to the meeting.As announced on 7 April 2020, the board of directors of NORBIT has changed its proposal for dividend from NOK 0.60 per share announced on 14 February 2020 to NOK 0.30 per share. In addition, the board proposes that it is given an authorisation from the general meeting to resolve additional distributions of dividends up to NOK 0.30 per share based on the annual accounts for...

Continue reading

Heineken N.V. withdraws all guidance for 2020 due to Covid-19

Amsterdam, 8 April 2020 – Heineken N.V. (EURONEXT: HEIA; OTCQX: HEINY) today issued the following statement.With the spread of the Covid-19 crisis to all geographies, multiple countries have taken far-reaching containment measures such as restrictions of movement for populations and outlet closures, sometimes combined with the mandatory lockdown of production facilities. This constitutes a major negative macro-economic development and as such it is having a significant impact on HEINEKEN’s markets and on its business in 2020.In these very trying times, HEINEKEN’s priority is to ensure the health and welfare of its employees, customers, and business partners. All HEINEKEN teams are mobilised to enable the company to face this unprecedented crisis in the best possible way, and to protect the long-term potential of its brands and businesses.For...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.